AlloVir IPO

AlloVir is a biotechnology specializing in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.

Register for Details

For more details on financing and valuation for AlloVir, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is AlloVir's ticker symbol?


What is AlloVir's stock price?

3.84 as of 5/25/23

Learn more about AlloVir

Forge green plus iconForge green minus icon

What is AlloVir funding to date?

AlloVir has raised $154.35MM.